PER 0.00% 8.0¢ percheron therapeutics limited

investor pres announcement. , page-12

  1. 4,149 Posts.
    Tacked on to the bottom of page 2 in the most recent 4c...
    *Note: It is anticipated that based on the Company’s expected R&D expenditure to 30 June 2014 that the Company is to receive an R&D Tax incentive refund of between $1M to $1.5M later in CY 2014.
    Based on their cash burn they will probably have the same amount of cash at the end of the year as they do now.
    Historically losses last 3 years pa 2.4m,1.8m,1.8m.
    Though in saying all that something needs to happen in the next 6 months. The likelihood of them securing cash via an upfront licensing payment would be fairly high imo should 1103 and 1102 be proved up. Similarly if the Scm trial was successful the option to hold onto it or licence it out would depend on the success of the other 2.
    Imo only one deal out of 3 needs to be done to make this company, as all these indications are potentially worth 100s of millions pa in sales.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.0¢
Change
0.000(0.00%)
Mkt cap ! $72.12M
Open High Low Value Volume
7.9¢ 8.0¢ 7.9¢ $12.63K 158.7K

Buyers (Bids)

No. Vol. Price($)
1 119 7.8¢
 

Sellers (Offers)

Price($) Vol. No.
8.0¢ 273231 2
View Market Depth
Last trade - 15.26pm 19/07/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.